Japan is no longer a market foreign medical device companies can afford to treat as “difficult […]
You fly in, you present, you charm the room. Heads nod. The technical team likes your […]
The surge I sensed at BioJapan 2025 in October reflects deliberate engineering rather than hype: targeted […]
A New Order is taking shape in Japan’s life sciences. Conference floors are packed, university benches […]
An A3 Executive Reference (2 pages) Japan rewards programs that are sequenced, evidenced, and locally socialized. […]
Cracking Japan’s Pharma Ecosystem: Field Notes from ~20 Years in the Trenches Japan rewards sequencing, proof, […]
Japan’s IVD sector remains highly structured and closely governed, benefiting from a mature healthcare infrastructure and […]
Japan has set ambitious goals to advance its bioeconomy, aiming to integrate biotechnology across various sectors […]
Japanese Market Opportunities in AI-Driven Elderly Care: Living, Health, and Medication Management The silver economy of […]